Philip Morris International's Earnings Preview: I'm Not Buying
Philip Morris International's Earnings Preview: I'm Not Buying
PM - Philip Morris International Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$192.40
DETAILS
HIGH:
$205.00
LOW:
$180.00
MEDIAN:
$195.00
CONSENSUS:
$192.40
UPSIDE:
5.94%
Stock News
Investors flock to Big Tobacco as companies pivot to vapes and pouches — as moral taboo goes up in smoke
For nearly a decade, pension funds and major endowments blacklisted cigarette makers under strict sustainability mandates.
What A $300,000 Portfolio Can Realistically Pay You Each Month
Three hundred thousand dollars sits in an awkward zone for income investors. It is too large to ignore and too small to coast on. With the 10-year Treasury recently around 4.4% and the federal funds target range at 3.50% to 3.75%, the question is how to make this account pay without taking more risk than... What A $300,000 Portfolio Can Realistically Pay You Each Month
Altria vs. Philip Morris International: Tobacco Still Makes a Great Stock. Which Is a Better Buy in 2026?
Altria maintains strong domestic dominance through its Marlboro brand and generates significant free cash flow from its U.S. operations. Philip Morris International is aggressively expanding its global smoke-free portfolio with brands like IQOS and ZYN in over 100 markets.
My Top High-Yield Dividend Stock to Buy for Passive Income, Even If There's a Stock Market Crash
Anchor your portfolio with this high-yield Dividend King.
FDA lets Philip Morris market Zyn nicotine pouches as less harmful than cigarettes
The FDA will allow 20 Philip Morris-owned Zyn nicotine pouch products to carry a modified-risk claim saying switching from cigarettes lowers the risk of several smoking-related diseases. The decision gives Philip Morris a major marketing win for one of the fastest-growing nicotine products as cigarette sales decline in the U.S.
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products
STAMFORD, CT--(BUSINESS WIRE)--Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke,.
Altria vs. Philip Morris International: Which Consumer Goods Stock Is a Better Buy in 2026?
Altria maintains a dominant position in the U.S. tobacco market with industry-leading net margins and a massive domestic distribution network. Philip Morris International is leading the global shift to smoke-free products with its Iqos and ZYN platforms across more than 100 markets.
US FDA proposes rule to tighten oversight of foreign tobacco makers
The U.S. Food and Drug Administration proposed a rule on Friday that would require foreign tobacco product makers to register their facilities and list products sold in the country.
The WSJ Leadership Institute Names Philip Morris International Among “Best Companies For the Future”
Philip Morris International Inc. (PMI) (NYSE: PM) has been named in the WSJ Leadership Institute's inaugural âBest Companies for the Futureâ ranking, which
The WSJ Leadership Institute Names Philip Morris International Among “Best Companies For the Future”
STAMFORD, CT--(BUSINESS WIRE)--Philip Morris International Inc. (PMI) (NYSE: PM) has been named in the WSJ Leadership Institute's inaugural “Best Companies for the Future” ranking, which evaluates large corporations on their ability to adapt and succeed in a rapidly evolving global environment. PMI ranks at #97 overall and is the third highest ranked company in the Food Beverage & Tobacco industry group after Coca-Cola and PepsiCo. Compiled by Bendable Labs for the WSJ Leadership Institute,.
WSJ Intelligence Study: Uniquely Human Skills Deemed "Non-Replicable" in Automated Future
STAMFORD, CT--(BUSINESS WIRE)--Philip Morris International (PMI) (NYSE: PM) and WSJ Intelligence, the in-house thought leadership consultancy for The Wall Street Journal's commercial sales organization, today revealed topline findings from a forthcoming study at Journal House during the Cannes Lions International Festival of Creativity. The study delivered a clear takeaway for global businesses: human cognition must be the absolute forefront of the modern corporate landscape. The findings show.
1 Dividend Powerhouse Retirees Can Lean On Even If Rates Hike
Philip Morris International (NYSE:PM | PM Price Prediction) is a tobacco giant in the middle of a profitable pivot, with smoke-free products now accounting for over 43% of net revenues through IQOS heat-not-burn devices and ZYN nicotine pouches.
3 Tobacco Stocks to Keep an Eye on Amid Market Headwinds
PM, BTI and MO are tackling volume pressures and rising costs by expanding smoke-free portfolios and adapting to changing consumer trends.
Philip Morris International Announces New Regional Leadership
Philip Morris International (PMI) (NYSE: PM) announced a series of regional leadership appointments that support its ongoing shift toward a smokeâfree future
Philip Morris: King Of Tobacco In Consolidation Stage - Wait For A Dip
PM's leadership in smoke-free products, profitable growth trends, and secure dividend prospects justify a Buy on pullbacks, especially for swing traders within the $150s–$180s range. Smoke-free revenues now comprise 43% of sales, with IQOS/ZYN/VEEV delivering double-digit volume growth in select regions, supporting the management's adj EPS growth target at 3Y CAGR of +10%. These may very well temper the risks from the declining cigarette volumes amid price sensitivity, attributed to the likely to remain higher inflationary pressure in the intermediate term.
Philip Morris International Declares Regular Quarterly Dividend of $1.47 Per Share
STAMFORD, CT--(BUSINESS WIRE)--Regulatory News: The Board of Directors of Philip Morris International Inc. (NYSE: PM) today declared a regular quarterly dividend of $1.47 per common share, payable on July 20, 2026, to shareholders of record as of June 25, 2026. The ex-dividend date is June 25, 2026. For more details on stock, dividends and other information, see www.pmi.com/dividend. Philip Morris International: A Global Smoke-Free Champion Philip Morris International is a leading international.
Philip Morris: IQOS And ZYN Offset Combustibles Volume Decline
Philip Morris International delivered strong FQ1 2026 results, with EPS of $1.96 and 9% YoY revenue growth, mostly driven by smoke-free products. But growth potential from smoke-free offerings, notably IQOS and ZYN, is tempered by declining combustible product sales. Despite the mixed dynamics, PM trades at a significant P/E premium to the sector and historical averages.
Counterfeit Cigarettes Drive EU Illicit Market Above 10% for First Time Since 2014
A new study detailing the scale of the illicit cigarette trade in the European Union (EU) shows that consumption of black-market cigarettes rose more than 7% y
Counterfeit Cigarettes Drive EU Illicit Market Above 10% for First Time Since 2014
STAMFORD, CT--(BUSINESS WIRE)--A new study detailing the scale of the illicit cigarette trade in the European Union (EU) shows that consumption of black-market cigarettes rose more than 7% year-on-year in 2025, reaching levels not seen in over a decade, with counterfeit cigarettes playing an increasingly significant role across member states. Philip Morris International (PMI) (NYSE: PM) reiterates its call for a coordinated response to illicit trade in Europe, built on evidence-based regulation.
Price Targets
Philip Morris price target raised to $182 from $168 at UBS
$182.00
(was $180.70)
UBS
Philip Morris price target raised to $200 from $190 at Morgan Stanley
$200.00
(was $173.66)
Morgan Stanley
Philip Morris price target lowered to $168 from $181.50 at UBS
$168.00
(was $157.11)
UBS
Philip Morris price target lowered to $190 from $205 at Morgan Stanley
$190.00
(was $156.58)
Eric Serotta
·
Morgan Stanley
Philip Morris price target lowered to $195 from $200 at Stifel
$195.00
(was $158.68)
Matthew Smith
·
Stifel Nicolaus
Philip Morris price target raised to $205 from $180 at Barclays
$205.00
(was $183.40)
Barclays
Philip Morris price target raised to $181.50 from $158 at UBS
$181.50
(was $180.24)
UBS
Philip Morris price target raised to $205 from $175 at Morgan Stanley
$205.00
(was $182.81)
Eric Serotta
·
Morgan Stanley
Philip Morris price target raised to $200 from $180 at Stifel
$200.00
(was $182.81)
Stifel Nicolaus
Philip Morris downgraded to Hold from Buy at Jefferies
$180.00
(was $173.62)
Edward Mundy
·
Jefferies
Philip Morris price target lowered to $175 from $182 at Morgan Stanley
$175.00
(was $152.00)
Eric Serotta
·
Morgan Stanley
Philip Morris price target lowered to $180 from $186 at Stifel
$180.00
(was $152.00)
Stifel Nicolaus
Stifel on Philip Morris (PM): 'We view the pullback in the shares as an attractive buying point'
$186.00
(was $150.17)
Matthew Smith
·
Stifel Nicolaus
Philip Morris price target raised to $181 from $170 at UBS
$181.00
(was $180.37)
Faham Baig
·
UBS
Philip Morris price target raised to $155 from $145 at Barclays
$155.00
(was $131.57)
Gaurav Jain
·
Barclays
Philip Morris price target raised to $142 from $135 at Deutsche Bank
$142.00
(was $131.41)
Damian McNeela
·
Deutsche Bank
Philip Morris price target raised to $132 from $118.50 at Citi
$132.00
(was $118.91)
Simon Hales
·
Citigroup
Philip Morris price target raised to $135 from $118 at Deutsche Bank
$135.00
(was $121.40)
Damian McNeela
·
Deutsche Bank
Philip Morris price target raised to $145 from $130 at Barclays
$145.00
(was $125.81)
Gaurav Jain
·
Barclays
Philip Morris price target raised to $139 from $125 at BofA
$139.00
(was $125.71)
Lisa Lewandowski
·
Bank of America Securities